The G All experiments were performed on HEK293 cells stably expressing the recombinant human MC4r; cAMP levels were measured directly using an ELISA (Amersham Pharmacia). Drugs were made up in HEPES buffered HBSS (with 0.5% BSA, pH 7.4) and incubated for 20mins at 37oC. In the presence of Ca2+ (1.3mM), Zn2+ stimulated a significant concentration-related increase in cAMP formation (4.62 ± 0.43 fold/basal at 100µM Zn2+, P<0.05, n=3). In the presence of the selective MC4r antagonist SHU9119 (10µM; Schioth et al., 1999), the effects of Zn2+ (100µM) were significantly reduced (1.48 ± 0.20 fold/basal, P<0.05, n=3), indicating that the effects were an action at the MC4r. The effects of increasing [Ca2+] on the actions of Zn2+ (330µM) at the MC4r were also investigated. Ca2+ inhibited Zn2+ stimulated cAMP formation (pEC50 of 3.98 ± 0.13, n=4); the inhibitory effects of Ca2+ were maximal at 1.3mM. There was also a component of activation, which was insensitive to the effects of Ca2+ at this [Zn2+]. Finally we suggest
that Zn2+ is able to functionally compete
with Ca2+ in its ability to regulate
agonist (NDP-MSH and
pEC50 values and Emax values for the effects of Zn2+ in the presence (top) and absence (bottom) of Ca2+ (n=3-5). In summary, we have shown that Ca2+ and Zn2+ ions can play a role in the regulation of cAMP formation by the MC4r in both agonist dependent and independent manners. These data may be of relevance to both the physiological role of the MC4r and to the development of assays to study its function. Holst, B., Elling,
CE., & Schwartz TW. (2002). J. Biol. Chem., 277, 47662-47770. |